Janelle M. Hoskins - Concepedia

Author

Janelle M. Hoskins

University of North Carolina at Chapel Hill

Also Known As

Alyasiri, A., Dong, Q., Dvorak, Anne, Halawa, Omar I., Hayward, Michele C., Hoskins, J.M., Hoskins, Janelle M, Hoskins, Janelle M., Hwang, James, J HOSKINS

109

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill The University of Sydney Royal North Shore Hospital Washington University in St. Louis Royal Prince Alfred Hospital

About

Janelle M. Hoskins is an author at University of North Carolina at Chapel Hill specializing in medicine, pharmacology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	21	1.1K
2	Public Health	3	3	138
3	Health Sciences	2	2	173
4	Natural Sciences	2	2	33
5	Allergy	1	1	35

Janelle M. Hoskins

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
UGT1A1*28 Genotype and Irinotecan-Induced Neutropenia: Dose Matters Janelle M. Hoskins, R. M. Goldberg, Peng Qu, JNCI Journal of the National Cancer Institute	2007	464
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas Pu Wang, Qiongzhu Dong, C. Zhang, Oncogene Isocitrate Dehydrogenase 1Somatic VariantMedicineLiver PhysiologyGenetics	2012	377
The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells Michelle L. Holland, Jill Panetta, Janelle M. Hoskins, Biochemical Pharmacology Cannabis UseMultidrug Resistant CellsHealth SciencesBiochemistryP-glycoprotein Transport	2006	156
Phase II Efficacy and Pharmacogenomic Study of Selumetinib (AZD6244; ARRY-142886) in Iodine-131 Refractory Papillary Thyroid Carcinoma with or without Follicular Elements D. Neil Hayes, Amy S. Lucas, Tawee Tanvetyanon, Clinical Cancer Research	2012	149
Imatinib Disposition and ABCB1 (MDR1, P-Glycoprotein) Genotype Howard Gurney, Ma‐Li Wong, Rosemary L. Balleine, Clinical Pharmacology & Therapeutics	2007	141
A comparison of methods for estimating the viable count of a suspension of tumour cells Janelle M. Hoskins, G. G. Meynell, F. K. Sanders Experimental Cell Research Tumor BiologyViable CountTumor HeterogeneityMedicineCancer Management	1956	136
Thymidylate Synthase and Methylenetetrahydrofolate Reductase Gene Polymorphisms and Toxicity to Capecitabine in Advanced Colorectal Cancer Patients Rohini Sharma, Janelle M. Hoskins, Laurent P. Rivory, Clinical Cancer Research	2008	106
Acetylation phenotype and cutaneous hypersensitivity to trimethoprim-sulphamethoxazole in HIV-infected patients Andrew Carr, Annette S. Gross, Janelle M. Hoskins, AIDS	1994	96
Galactose-α-1,3-Galactose–Specific IgE Is Associated with Anaphylaxis but Not Asthma Scott P. Commins, Libby A. Kelly, Eva Rönmark, American Journal of Respiratory and Critical Care Medicine	2012	79
Irinotecan Pharmacogenetics: Influence of Pharmacodynamic Genes Janelle M. Hoskins, Eugenio Marcuello, Albert Altés, Clinical Cancer Research	2008	77

Page 1